To the full analysis
Buyback calculator for Bausch Health Companies
Bausch Health Companies stock: key metrics
BHCBausch Health Companies had an operating margin of 21.3% and a return on invested capital (ROIC) of 5.4% in fiscal 2025.
Margins show how much of revenue is left over, returns on capital how hard the invested money works.
Daily figure as of 13 Nov 2026
Margins
- Gross margin
- Operating margin
- Net margin
Figures as a table
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| 2006 | 79.1% | 42.4% | 19.6% |
| 2007 | 73.5% | 22.3% | 23.2% |
| 2008 | 74.0% | 25.9% | 26.4% |
| 2009 | 60.4% | 22.1% | 21.5% |
| 2010 | 64.6% | −9.6% | −18.2% |
| 2011 | 70.5% | 21.3% | 6.5% |
| 2012 | 74.4% | 2.3% | −3.3% |
| 2013 | 73.5% | −7.1% | −15.0% |
| 2014 | 73.1% | 24.4% | 10.7% |
| 2015 | 76.6% | 14.6% | −2.6% |
| 2016 | 73.4% | −5.9% | −24.9% |
| 2017 | 70.8% | 1.2% | 27.6% |
| 2018 | 71.9% | −28.4% | −49.5% |
| 2019 | 72.7% | −2.4% | −20.7% |
| 2020 | 72.0% | 8.4% | −7.0% |
| 2021 | 71.6% | 5.3% | −11.2% |
| 2022 | 70.9% | 5.6% | −2.8% |
| 2023 | 70.8% | 11.0% | −6.8% |
| 2024 | 71.1% | 16.1% | −0.5% |
| 2025 | 70.7% | 21.3% | 1.5% |
Returns on capital
- ROE
- ROIC
- ROA
Figures as a table
| Year | ROE | ROIC | ROA |
|---|---|---|---|
| 2006 | 16.1% | 48.5% | 9.7% |
| 2007 | 15.1% | 20.3% | 11.0% |
| 2008 | 16.6% | 21.7% | 12.3% |
| 2009 | 13.0% | 14.0% | 8.5% |
| 2010 | −4.2% | −1.8% | −1.9% |
| 2011 | 4.1% | 4.5% | 1.2% |
| 2012 | −3.1% | 0.5% | −0.6% |
| 2013 | −16.9% | −1.8% | −3.1% |
| 2014 | 16.7% | 7.9% | 3.3% |
| 2015 | −4.5% | 4.2% | −0.5% |
| 2016 | −76.4% | −1.3% | −5.5% |
| 2017 | 41.1% | 0.3% | 6.4% |
| 2018 | −100.0% | −6.6% | −15.1% |
| 2019 | −100.0% | −0.6% | −5.3% |
| 2020 | −100.0% | 2.2% | −1.8% |
| 2021 | 200.0% | 1.5% | −3.2% |
| 2022 | 32.5% | 1.7% | −0.9% |
| 2023 | 57.9% | 3.6% | −2.2% |
| 2024 | 3.6% | 3.7% | −0.2% |
| 2025 | −28.4% | 5.4% | 0.6% |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 2 Oct 2026)
- Valuation signal Fairly valued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.